Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06435676
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-05-24
Brief Title:
A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects
Sponsor:
Fujian Shengdi Pharmaceutical Co Ltd
Organization:
Fujian Shengdi Pharmaceutical Co Ltd
Study Overview
Official Title:
A Phase I Study of the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of HRS9531 Tablets in Healthy Subjects
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is being conducted to evaluate the safety tolerability pharmacokinetics and pharmacodynamics of single and multiple doses of HRS9531tablets in healthy subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None